Physician profile
Sylvanus Ly
NPI 1053977579
$415.59
in general payments reported to CMS, 2019-2025
8 companies · $71.16 in 2025
The $71.16 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $219 · 2024: $125 · 2025: $71.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $415.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hydrocision, INC. | $172.24 | 2023 | Tenjet |
| Averitas Pharma INC. | $51.89 | 2023-2024 | Qutenza |
| Bioventus LLC | $49.37 | 2024-2025 | Durolane, Exogen Ultrasound Bone Healing System |
| Davol INC. | $35.66 | 2024 | Arista Ah Flexitip |
| Amgen INC. | $32.88 | 2024 | Prolia, Evenity |
| Vertex Pharmaceuticals Incorporated | $29.99 | 2025 | |
| Midsouth Orthopedics INC. | $27.11 | 2023 | |
| Solventum Corporation | $16.45 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sylvanus Ly listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.